Aishwarya Nair's Profile
![Aishwarya Nair Aishwarya Nair](https://www.medindia.net/images/content-team-medindia/aishwarya-nair.jpg)
Aishwarya is currently studying Doctor of Pharmacy (Pharm D) at Pune University. In academics her position stands within first five ranks in Pune university exams. She has also done internship at a Mumbai based hospital during her vacations. She was posted as a critical care clinical pharmacist. She view more..
Written / Edited / Medically Reviewed
![CDC Shortens COVID-19 Quarantine Period to 7-10 Days](https://www.medindia.net/health-images/boost-your-mental-health-during-social-distancing.jpg)
CDC Shortens COVID-19 Quarantine Period to 7-10 Days
CDC announces quarantine period now reduced to 7-10 days along with certain conditions. CDC also requests the public to postpone their winter travel. Stay home stay safe.
![Setmelanotide - First Drug to Treat Rare Genetic Causes of Severe Obesity Approved by FDA](https://www.medindia.net/health-images/food-addiction.jpg)
Setmelanotide - First Drug to Treat Rare Genetic Causes of Severe Obesity Approved by FDA
Setmelanotide has been approved by the US FDA for weight to treat rare genetic causes of severe obesity in adults and children as young as 6 years of age.
![New Experimental Drug Helps Treat Antibiotic Resistant Bacteria](https://www.medindia.net/health-images/probiotic-supplementation-reduce-antibiotic-resistance.jpg)
New Experimental Drug Helps Treat Antibiotic Resistant Bacteria
An experimental drug being tested to treat neurodegenerative disease may help fight against life- threatening antibiotic resistant bacteria, suggests a study
![Discontinuing Tyrosine Kinase Inhibitors can Improve Outcomes in Leukemia Patients](https://www.medindia.net/health-images/tyrosine-kinase-inhibitor-could-cure-chronic-myeloid-leukemia.jpg)
Discontinuing Tyrosine Kinase Inhibitors can Improve Outcomes in Leukemia Patients
Discontinuing Tyrosine Kinase inhibitor (TKI) in patients suffering from chronic myeloid leukemia (CML) has shown better patient reported outcomes.
![MHRA Issues a Drug Safety Alert After Fatal Cases of Liver Injury With Lung Antifibrotics](https://www.medindia.net/health-images/wbc-dysfunction-in-ards.jpg)
MHRA Issues a Drug Safety Alert After Fatal Cases of Liver Injury With Lung Antifibrotics
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety alert for the use of Pirfenidone as it is shown to cause severe liver toxicity.